Top Environmental Fate Ecotoxicology Human Health Translations
Home
A to Z
Search
Support
Edit history
Purchasing and licensing
NEW
- New support docs available
- Newsletter Aug 2025
- User survey
Tiletamine hydrochloride
Last updated: 16/09/2025
(Not known by any other names)

GENERAL INFORMATION
Description
A veterinary anaesthetic which is related chemically to ketamine and commonly used in combination with zolazepam
Examples of veterinary uses
Anxiety management. Also used to control convulsions and to induce sedation for veterinary surgical procedures
Examples of species treated
Cats; Dogs; Polar bears
Approval status
VMR 2013/2033 approval status (GB/UK)
Approved - usually supplied as a prescription only medicine to be authorised by a veterinarian (POM-V)
EU Regulatory approval status
Approved
Chemical structure
Isomerism
Tiletamine hydrochloride exhibits diastereomerism, due to the presence of a chiral centre at the carbon atom adjacent to the cyclohexanone ring. This chiral centre allows tiletamine to exist as two stereoisomers: (R)- and (S)-enantiomers. In commercial formulations like tiletamine is typically used as a racemic mixture.
Chemical formula
C₁₂H₁₈ClNOS
Canonical SMILES
CCNC1(CCCCC1=O)C2=CC=CS2.Cl
Isomeric SMILES
-
International Chemical Identifier key (InChIKey)
ZUYKJZQOPXDNOK-UHFFFAOYSA-N
International Chemical Identifier (InChI)
InChI=1S/C12H17NOS.ClH/c1-2-13-12(11-7-5-9-15-11)8-4-3-6-10(12)14;/h5,7,9,13H,2-4,6,8H2,1H3;1H
2D structure diagram/image available?
Yes
General status
Veterinary substance type
Medicinal drug, Anaesthetic, Sedative
Substance groups
Unclassified medicinal drug
Minimum active substance purity
-
Known relevant impurities
-
Substance origin
Synthetic
Mode of action
NMDA receptor antagonist. It generates a so-called dissociative anaesthesia because it depresses certain cerebral regions whilst other regions, in particular the limbic system, remain active.
Molecular targets
[NMDA receptor, Antagonist]
CAS RN
14176-50-2
EC number
604-248-6
CIPAC number
-
US EPA chemical code
-
PubChem CID
26543
Therapeutic Class
Nervous system: Other general anaesthetics
ATCvet Code
QN02AX99
Controlled Drug?
No
Regulation 37/2010 MRL Classification
-
Molecular mass
259.8
PIN (Preferred Identification Name)
2-(ethylamino)-2-thiophen-2-ylcyclohexan-1-one;hydrochloride
IUPAC name
2-(ethylamino)-2-thiophen-2-ylcyclohexan-1-one;hydrochloride
CAS name
-
Forever chemical
-
Other status information
-
Relevant Environmental Water Quality Standards
-
Physical state
White crystalline solid
Related substances & organisms
Commercial
Property
Value
Availability status
Current
Introduction & key dates
Circa 1965, first synthesised; 1980s, global agricultural use begins; 2015, first approvals China
Example manufacturers & suppliers of products using this active now or historically
  • Virbac Ltd
Example products using this active
  • Zoletil
Formulation and application details
Typically formulated as part of a combination injectable anaesthetic, most commonly paired with zolazepam hydrochloride
Commercial production
The production of tiletamine hydrochloride involves a multi-step synthetic pathway starting with the formation of cyclopentyl 2-thienyl ketone. This key intermediate is typically synthesized via a Friedel–Crafts acylation of thiophene with cyclopentanecarboxylic acid chloride, often catalysed by aluminium trichloride or graphite for improved yields. The ketone is then halogenated and reacted with an amine to form a substituted amino ketone. Through thermal rearrangement and reductive amination, the structure is refined into the active tiletamine base. Finally, the base is treated with hydrochloric acid to yield the hydrochloride salt.
Impact on climate of production and use
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used.
ENVIRONMENTAL FATE
Property
Value
Source; quality score; and other information
Interpretation
Solubility - In water at 20 °C (mg l⁻¹)
- - -
Solubility - In organic solvents at 20 °C (mg l⁻¹)
20000
Q3 Q = Miscellaneous data from online sources
3 = Unverified data of known source
Ethanol
-
Melting point (°C)
186
Q3 Q = Miscellaneous data from online sources
3 = Unverified data of known source
-
Boiling point (°C)
352.6
Q3 Q = Miscellaneous data from online sources
3 = Unverified data of known source
-
Degradation point (°C)
- - -
Flashpoint (°C)
- - -
Octanol-water partition coefficient at pH 7, 20 °C
P
- - -
Log P
- - -
Fat solubility of residues
Solubility
- - -
Data type
- - -
Density (g ml⁻¹)
- - -
Dissociation constant pKa) at 25 °C
- - -
-
Vapour pressure at 20 °C (mPa)
- - -
Henry's law constant at 25 °C (Pa m³ mol⁻¹)
- - -
Volatilisation as max % of applied dose lost
From plant surface
- - -
From soil surface
- - -
Maximum UV-vis absorption L mol⁻¹ cm⁻¹
- - -
Surface tension (mN m⁻¹)
- - -
Refractive Index
- - -
Environmental release
-
Degradation
Property
Value
Source; quality score; and other information
Interpretation
Soil degradation (days) (aerobic)
DT₅₀ (typical)
- - -
DT₅₀ (lab at 20 °C)
- - -
DT₅₀ (field)
- - -
DT₉₀ (lab at 20 °C)
- - -
DT₉₀ (field)
- - -
Note
-
Manure DT₅₀ (days)
- - -
Aqueous photolysis DT₅₀ (days) at pH 7
Value
- - -
Note
-
Aqueous hydrolysis DT₅₀ (days) at 20 °C and pH 7
Value
- - -
Note
-
Water-sediment DT₅₀ (days)
- - -
Water phase only DT₅₀ (days)
- - -
Sediment phase only DT₅₀ (days)
- - -
Air degradation
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below.
Decay in stored produce DT₅₀
-
Soil adsorption and mobility
Property
Value
Source; quality score; and other information
Interpretation
Linear
Kd (mL g⁻¹)
- - -
Koc (mL g⁻¹)
-
Notes and range
-
Freundlich
Kf (mL g⁻¹)
- - -
Kfoc (mL g⁻¹)
-
1/n
-
Notes and range
-
pH sensitivity
-
Fate indices
Property
Value
Source; quality score; and other information
Interpretation
GUS leaching potential index
- - -
Bio-concentration factor
BCF (l kg⁻¹)
- - -
CT₅₀ (days)
- -
Known metabolites

None

ECOTOXICOLOGY
Terrestrial ecotoxicology
Property
Value
Source; quality score; and other information
Interpretation
Mammals - Acute oral LD₅₀ (mg kg⁻¹)
160
Q3 Q = Miscellaneous data from online sources
3 = Unverified data of known source
Mouse
Moderate
Mammals - Short term dietary NOEL
(mg kg⁻¹)
- - -
(ppm diet)
- -
Mammals - Chronic 21d NOAEL (mg kg⁻¹ bw d⁻¹)
- - -
Birds - Acute LD₅₀ (mg kg⁻¹)
- - -
Birds - Short term dietary (LC₅₀/LD₅₀)
- - -
Birds - Chronic 21d NOEL (mg kg⁻¹ bw d⁻¹)
- - -
Earthworms - Acute 14 day LC₅₀ (mg kg⁻¹ dw soil)
- - -
Earthworms - Chronic NOEC, reproduction (mg kg⁻¹ dw soil)
- - -
Soil micro-organisms
- - -
Collembola
Acute LC₅₀ (mg kg⁻¹)
- - -
Chronic NOEC (mg kg⁻¹)
- - -
Non-target plants
Vegetative vigour ER₅₀ (g ha⁻¹)
- - -
Seedling emergence ER₅₀ (g ha⁻¹)
- - -
Honeybees (Apis spp.)
Contact acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
Oral acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
Unknown mode acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
Chronic
- - -
Notes
-
Bumblebees (Bombus spp.)
Contact acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
-
Oral acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
-
Mason bees (Osmia spp.)
Contact acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
Oral acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg bee⁻¹)
- - -
Other bee species (1)
Acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg insect⁻¹)
- - -
Mode of exposure
-
Other bee species (2)
Acute LD₅₀ (worst case from 24, 48 and 72 hour values - μg insect⁻¹)
- - -
Mode of exposure
-
Beneficial insects (Ladybirds)
- - -
Beneficial insects (Lacewings)
- - -
Beneficial insects (Parasitic wasps)
- - -
Beneficial insects (Predatory mites)
- - -
Beneficial insects (Ground beetles)
- - -
Aquatic ecotoxicology
Property
Value
Source; quality score; and other information
Interpretation
Temperate Freshwater Fish - Acute 96 hour LC₅₀ (mg l⁻¹)
- - -
Temperate Freshwater Fish - Chronic 21 day NOEC (mg l⁻¹)
- - -
Tropical Freshwater Fish - Acute 96 hour LC₅₀ (mg l⁻¹)
- - -
Temperate Freshwater Aquatic invertebrates - Acute 48 hour EC₅₀ (mg l⁻¹)
- - -
Temperate Freshwater Aquatic invertebrates - Chronic 21 day NOEC (mg l⁻¹)
- - -
Tropical Freshwater Aquatic invertebrates - Acute 48 hour EC₅₀ (mg l⁻¹)
- - -
Aquatic crustaceans - Acute 96 hour LC₅₀ (mg l⁻¹)
- - -
Sediment dwelling organisms - Acute 96 hour LC₅₀ (mg l⁻¹)
- - -
Sediment dwelling organisms - Chronic 28 day NOEC, static, water (mg l⁻¹)
- - -
Sediment dwelling organisms - Chronic 28 day NOEC, sediment (mg kg⁻¹)
- - -
Aquatic Plants (free-floating, fonds growth, fresh) - 7 day (mg l⁻¹)
- - -
Aquatic plants (rooted, growth rate, fresh) - 14 day (mg l⁻¹)
- - -
Algae - Acute (growth rate, fresh; mg l⁻¹)
- - -
Algae - Chronic (growth rate, fresh; mg l⁻¹)
- - -
Mesocosm study data
NOEAEC mg l⁻¹
- - -
NOEAEC mg l⁻¹
- - -
Marine bivalves
- - -
HUMAN HEALTH AND PROTECTION
General
Property
Value
Source; quality score; and other information
Interpretation
Threshold of Toxicological Concern (Cramer Class)
- - -
Mammals - Acute oral LD₅₀ (mg kg⁻¹)
160
Q3 Q = Miscellaneous data from online sources
3 = Unverified data of known source
Mouse
Moderate
Mammals - Dermal LD₅₀ (mg kg⁻¹ body weight)
- - -
Mammals - Inhalation LC₅₀ (mg l⁻¹)
- - -
Other Mammal toxicity endpoints
- - -
ADI - Acceptable Daily Intake (mg kg⁻¹ bw day⁻¹)
- - -
ARfD - Acute Reference Dose (mg kg⁻¹ bw day⁻¹)
- - -
AAOEL - Acute Acceptable Operator Exposure Level (mg kg⁻¹ bw day⁻¹)
- - -
AOEL - Acceptable Operator Exposure Level - Systemic (mg kg⁻¹ bw day⁻¹)
- - -
Dermal penetration studies (%)
- - -
Dangerous Substances Directive 76/464
- - -
Exposure Routes
Public
-
Occupational
-
Mammalian dose elimination route and rate
Metabolised in the liver, excreted via the kidneys
Q3 Q = Miscellaneous data from online sources
3 = Unverified data of known source
-
Health issues
Specific human health issues (hazard-based)
Carcinogen
Genotoxic
Endocrine disruptor
No data found
A0 A = Chromosome aberration (EFSA database)
0 = No data
;
B0 B = DNA damage/repair (EFSA database)
0 = No data
;
C0 C = Gene mutation (EFSA database)
0 = No data
;
D0 D = Genome mutation (EFSA database)
0 = No data
;
E0 E = Unspecified genotoxicity type (miscellaneous data source)
0 = No data
No data found
Reproduction / development effects Acetyl cholinesterase inhibitor Neurotoxicant
Yes, known to cause a problem
No data found No data found
Respiratory tract irritant Skin irritant Skin sensitiser
No data found No data found No data found
Eye irritant Phototoxicant  
No data found No data found  
General human health issues
May cause drowsiness
Handling issues
Property
Value and interpretation
General
IMDG Transport Hazard Code 6.1
CLP classification 2013
Health: H301, H361, H336
WHO Classification
Not listed (Not listed)
UN Number
UN2811
Waste disposal & packaging
Packaging group III (minor danger)
Shelf-life, storage, stability and reactivity
-
TRANSLATIONS
Language
Name
English
tiletamine hydrochloride
French
-
German
-
Danish
-
Italian
-
Spanish
-
Greek
-
Polish
-
Swedish
-
Hungarian
-
Dutch
-
Norwegian
-

Record last updated: 16/09/2025
Contact: aeru@herts.ac.uk
Please cite as: Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242